Consultation record

Submissions noted, no amendment

The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.

Submissions

127 documents · page 1 of 5

Table 1. Submissions with this disposition, on this page.

Reference	Consultation	Respondent	Point raised
DRAFT-CERTAINTY-FR/008	Draft revision of the Institute’s certainty assessment framework…	Dr Vasilisa Immelmann	The document should describe how an assessment becomes a decision
DRAFT-CERTAINTY-FR/005	Draft revision of the Institute’s certainty assessment framework…	Dr Oswin Yorkstone	Declared interests should appear on the document rather than on a separate page
DRAFT-CERTAINTY-FR/011	Draft revision of the Institute’s certainty assessment framework…	Dr Anselm Ashworth-Danquah	A superseded version should remain reachable from the version that replaced it
DRAFT-SUPPLIER-RUB/008	Draft supplier evaluation rubric	Dr Rurik Underhill-Okafor	A superseded version should remain reachable from the version that replaced it
DRAFT-SEMAGLUTIDE-/007	Draft monograph: semaglutide, version 3	Dr Dmitri Nordhagen	A sortable table implies a comparison the underlying data do not support
DRAFT-SEMAGLUTIDE-/006	Draft monograph: semaglutide, version 3	Dr Jolyon Grünbaum-Sowande	A superseded version should remain reachable from the version that replaced it
DRAFT-TIRZEPATIDE-/008	Draft monograph: tirzepatide, version 2	Dr Liesbeth Quenneville	Declared interests should appear on the document rather than on a separate page
DRAFT-TIRZEPATIDE-/011	Draft monograph: tirzepatide, version 2	Hortensia Hollingworth	The monograph should not describe how the compound is supplied outside a regulated route
DRAFT-TIRZEPATIDE-/001	Draft monograph: tirzepatide, version 2	Dr Rukayat Zaleski-Mbeki	A superseded version should remain reachable from the version that replaced it
DRAFT-WEIGHT-REGAI/009	Draft synthesis: weight change after discontinuation of an incretin…	Dr Eamon Sandringham-Adu	Baseline imbalance in a small contributing trial is not remarked on
DRAFT-NETWORK-TRAN/005	Draft methodological review: transitivity in the incretin network	Dr Quintus Rautavaara	Declared interests should appear on the document rather than on a separate page
DRAFT-CONFLICTS-PO/009	Draft conflicts-of-interest policy	Dr Rukayat Zaleski-Mbeki	The Institute publishes no telephone number and no messaging channel
DRAFT-CONFLICTS-PO/004	Draft conflicts-of-interest policy	Dr Wolfram Kaltenbach-Mensah	Declared interests should appear on the document rather than on a separate page
DRAFT-FUNDING-POLI/006	Draft funding and sponsorship policy	Dr Kamila Glendinning-Uche	Declared interests should appear on the document rather than on a separate page
DRAFT-FUNDING-POLI/009	Draft funding and sponsorship policy	Ludmila Brackenridge	A sortable table implies a comparison the underlying data do not support
DRAFT-PROGRAMME-RE/005	Draft policy: labelling of Institute-constructed programme records	Dr Amara Quaresma	Declared interests should appear on the document rather than on a separate page
DRAFT-PROGRAMME-RE/010	Draft policy: labelling of Institute-constructed programme records	Dr Georgiana Zimmerthal	A sortable table implies a comparison the underlying data do not support
DRAFT-PROGRAMME-RE/012	Draft policy: labelling of Institute-constructed programme records	Dr Sigrún Lavrentiev industry	The disclosure requirements exceed those of comparable bodies
DRAFT-PROGRAMME-RE/011	Draft policy: labelling of Institute-constructed programme records	Radoslava Palmgren-Kofi	A superseded version should remain reachable from the version that replaced it
DRAFT-ENDOTOXIN-ST/005	Draft standard: bacterial endotoxin testing of peptide presentations	Dr Adaeze Dunmore-Ekpo	A superseded version should remain reachable from the version that replaced it
DRAFT-ANALYTICAL-S/006	Draft scope of the analytical and methodological standards series	Dr Mordecai Bellingham-Ojo	A multi-part document does not indicate how many parts it has
DRAFT-GLP1-OBESITY/011	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Ivo Quintanilha	Declared interests should appear on the document rather than on a separate page
DRAFT-LEAN-MASS-SC/005	Draft scoping review: change in lean mass during pharmacologically…	Dr Jolyon Grünbaum-Sowande	Baseline imbalance in a small contributing trial is not remarked on
DRAFT-GASTROPARESI/011	Draft safety review: delayed gastric emptying and procedural sedation	Dr Katarzyna Oppenheimer-Ade	Baseline imbalance in a small contributing trial is not remarked on
DRAFT-SUPPLIER-DOS/009	Draft format of the supplier dossier series	Ludmila Brackenridge	A superseded version should remain reachable from the version that replaced it
DRAFT-SUPPLIER-DOS/006	Draft format of the supplier dossier series	Dr Kamila Glendinning-Uche	Declared interests should appear on the document rather than on a separate page
DRAFT-SUPPLIER-DOS/007	Draft format of the supplier dossier series	Dr Wilhelmina Wintringham	A multi-part document does not indicate how many parts it has
DRAFT-PEOPLE-REGIS/005	Draft policy on the register of members and reviewers	Valentin Tollemache	The Institute publishes no telephone number and no messaging channel
DRAFT-PEOPLE-REGIS/003	Draft policy on the register of members and reviewers	Dr Hyacinth Drakeford-Amadi	A sortable table implies a comparison the underlying data do not support
DRAFT-PEOPLE-REGIS/001	Draft policy on the register of members and reviewers	Dr Zdenka Nyquist-Obiora	A superseded version should remain reachable from the version that replaced it

page 1 of 5